RESEARCHER PROFILE (Filmed May 2024)
Dr Shelley Keating AES AEP ESSAM
Senior Lecturer, Clinical Exercise Physiology and Accredited Exercise Physiologist
School of Human Movement and Nutrition Sciences
The University of Queensland
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
Dr Keating has an established research profile that is delivering impact for patients and clinicians. Her research has led to the development of safe and feasible exercise programs that generate significant improvement in the cardiometabolic health of individuals with MASLD and related chronic disease. Drawing on these findings, Dr Keating has developed national and international exercise guidelines for MASLD. Her research has led to a paradigm shift in how exercise is prioritised in MASLD management and has been adopted into exercise prescription recommendations in 15 international guidelines for MASLD management across 12 countries.
Dr Keating’s research had found a lack of awareness, uptake, and sustainability of exercise for MASLD management. Her ongoing program of research is informed by, and co-designed with, people with MASLD and related chronic disease, to find sustainable exercise solutions.
Her contribution to the field was recognised by the prestigious 2020 Australia and New Zealand Obesity Society Young Investigator award. Shelley has been an ESSA (Exercise & Sports Science Australia) member since 2007 and has 16 years of clinical AEP experience in people with cardiometabolic disease including MAFLD.
Her mission is to change the way that exercise is prioritised, accessed, and delivered to improve the health and wellbeing of people with MASLD and related type 2 diabetes.
Source: Supplied & ESSA (Exercise & Sports Science Australia)
Note: AES is the acronym for Accredited Exercise Scientist (AES), AEP is the acronym for Accredited Exercise Physiologist, ESSAM is the acronym for Exercise & Sports Science Australia Member.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
-
Interventions for improving outcomes of children who are deaf or hard of hearing
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.
-
Vaccine effectiveness against infections triggering autoimmune disease
Dr Deborah Burnett is a Scientia Senior Lecturer and Laboratory Head at UNSW, where she leads a multidisciplinary research program spanning mechanistic immunology and translational vaccinology. Her work focuses on understanding how immune responses can protect against challenging infectious threats, including bacterial infections and infections associated with autoimmune disease.
